Why is Bariatric Surgery So Effective?

Dr. Lee Kaplan discusses the role of the gastrointestinal tract and gut microbiota in the mechanism of action of bariatric surgery.

Bariatric surgery is one of the most effective treatments of obesity in adults. Unlike many drugs prescribed for the treatment of obesity, bariatric surgery has a broad range of effects, including physiological impact on the gastrointestinal tract and gut microbiota.

In this final installment of our Obesity 2020 webinar series, Dr. Lee Kaplan discusses late-breaking research and reviews various mechanisms of action of bariatric and metabolic surgery and how they affect the regulation of energy balance and metabolic function.

Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video viewer.

Resources

#ExpertAnswers: Lee Kaplan on Obesity

Why is Bariatric Surgery so Effective? from InsideScientific

To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.

Presenters

Lee M. Kaplan, MD, PhD, FTOS

Director
Obesity, Metabolism, and Nutrition Institute
Massachusetts General Hospital

Lee M. Kaplan, MD, PhD, is director of the Obesity, Metabolism, and Nutrition Institute and founding director of the Weight Center at Massachusetts General Hospital (MGH), and associate professor of medicine at Harvard Medical School (HMS). His research focuses on the role of the gastrointestinal tract and gut microbiota in the regulation of energy balance and metabolic function, including the mechanism of action of bariatric and metabolic surgery, as well as the genetic determinants of obesity and its response to therapy. Dr. Kaplan is director of the subspecialty fellowship program in Obesity Medicine and Nutrition at MGH, director of the Blackburn Course in Obesity Medicine at Harvard Medical School, chair of the U.S. Obesity Medicine Fellowship Council, and associate director of the National Institutes of Health (NIH)-sponsored Nutrition and Obesity Research Center at Harvard. He has served in many professional leadership roles and is a past president of The Obesity Society.

Additional Content From American Physiological Society

Molecular Signals Mediating Increases in Muscle Size and Function

In this webinar, Dr. Bert Blaauw elucidates skeletal muscle regulatory pathways and offers approaches to tackle muscle deficits for therapy.

Getting to the Heart of Cardiovascular Research: From Yesterday to Today and Looking Towards Tomorrow

Dr. Melanie White presents the various methods for assessing cardiac function in the context of pathology, spanning from in vitro to in vivo techniques, and how she integrates these with cutting-edge mass spectrometry in her research on cardiovascular disease pathogenesis.

Updates in Chronic Traumatic Encephalopathy (CTE)

Dr. Ann McKee will describe the emergence of chronic traumatic encephalopathy (CTE) as a distinct disease over the past 20 years.

Additional Content From The Obesity Society

Anti-Obesity Pharmacotherapy: Where are we now? Where are we going?

OBESITY SERIES 2020: Dr. Ania Jastreboff discusses the current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps.